NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Animal Biosciences, Inc.

Animal Biosciences, Inc.

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://leapyears.com/

Last Round

Series C

Feb 11, 2026

Total Funding Raised

$217M

Company Overview

Animal Biosciences, Inc. is an animal health company that develops supplements and therapeutics to combat the root causes of aging in companion animals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Subscription Commerce, Home & Lifestyle

Business Model

B2C

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Non-AI

Keywords

pet supplementsdog longevityNAD+ precursorpet healthdog wellnessbiohacking for petsveterinary wellnesscellular healthdog cognitive supportDTC pet brandpet healthspansubscription pet foodsenolytic supplements

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Animal Biosciences, Inc. Comparables

Compare Animal Biosciences, Inc. with similar companies based on industry and business-model similarity.

Animal Biosciences, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Animal Biosciences, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 11, 2026
Series B ExtensionFeb 26, 2025
DebtMar 21, 2024
Series BMar 21, 2024
Series ASep 23, 2021

Animal Biosciences, Inc. Investors

Notable investors and investment history

Animal Biosciences, Inc. investors
InvestorRounds
Bain Capital VenturesSeries B
Khosla VenturesSeries B, Series A
age1Series C
Collaborative FundSeed, Series A, Series B, Series B Extension
First Round CapitalSeed, Series A, Series B
BoxGroupSeed, Series A, Series B
The Longevity FundSeed, Series A

Animal Biosciences, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Animal Biosciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Animal Biosciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Year Founded2017
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.